These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16443890)

  • 1. Clustering of cardiovascular risk factors associated with the insulin resistance syndrome: assessment by principal component analysis in young hyperandrogenic women.
    Zanolin ME; Tosi F; Zoppini G; Castello R; Spiazzi G; Dorizzi R; Muggeo M; Moghetti P
    Diabetes Care; 2006 Feb; 29(2):372-8. PubMed ID: 16443890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin and metabolic syndrome in obese and non-obese children.
    Moreno LA; Pineda I; Rodríguez G; Fleta J; Giner A; Juste MG; Sarría A; Bueno M
    Horm Metab Res; 2002 Jul; 34(7):394-9. PubMed ID: 12189588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
    Meigs JB; D'Agostino RB; Wilson PW; Cupples LA; Nathan DM; Singer DE
    Diabetes; 1997 Oct; 46(10):1594-600. PubMed ID: 9313755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
    Nader S; Riad-Gabriel MG; Saad MF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin as a component of the insulin resistance syndrome.
    Fernández-Real JM; Ricart-Engel W; Arroyo E; Balançá R; Casamitjana-Abella R; Cabrero D; Fernández-Castañer M; Soler J
    Diabetes Care; 1998 Jan; 21(1):62-8. PubMed ID: 9580307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-metabolic risk factors among young infertile women: a systematic review and meta-analysis.
    Mulder CL; Lassi ZS; Grieger JA; Ali A; Jankovic-Karasoulos T; Roberts CT; Andraweera PH
    BJOG; 2020 Jul; 127(8):930-939. PubMed ID: 32048421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor analysis of metabolic syndrome components in obese women.
    Lafortuna CL; Adorni F; Agosti F; Sartorio A
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In addition to obesity and insulin resistance, microalbuminuria and diminished insulin secretion are linked with the metabolic syndrome in community-dwelling nondiabetic Taiwanese subjects.
    Yang YC; Wu JS; Lu FH; Chang WC; Wu CH; Chang CJ
    Diabetes Res Clin Pract; 2007 Apr; 76(1):102-10. PubMed ID: 16956689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study.
    Bonora E; Targher G; Zenere MB; Saggiani F; Cacciatori V; Tosi F; Travia D; Zenti MG; Branzi P; Santi L; Muggeo M
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):975-80. PubMed ID: 8923153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study.
    Donahue RP; Bean JA; Donahue RD; Goldberg RB; Prineas RJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2413-7. PubMed ID: 9409209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
    Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature.
    Maison P; Byrne CD; Hales CN; Day NE; Wareham NJ
    Diabetes Care; 2001 Oct; 24(10):1758-63. PubMed ID: 11574438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome].
    Metzler W; Fücker K; Schwanebeck U; Hanefeld M; Julius U; Kindel B; Fischer S
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1941-6. PubMed ID: 14502445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
    Bortolasci CC; Vargas HO; Vargas Nunes SO; de Melo LG; de Castro MR; Moreira EG; Dodd S; Barbosa DS; Berk M; Maes M
    J Affect Disord; 2015 Jul; 179():148-55. PubMed ID: 25863911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in an animal model of polycystic ovary disease is aggravated by vitamin D deficiency: Vascular consequences.
    Hadjadj L; Várbíró S; Horváth EM; Monori-Kiss A; Pál É; Karvaly GB; Heinzlmann A; Magyar A; Szabó I; Sziva RE; Benyó Z; Buday M; Nádasy GL
    Diab Vasc Dis Res; 2018 Jul; 15(4):294-301. PubMed ID: 29465004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
    Cupisti S; Kajaia N; Dittrich R; Duezenli H; W Beckmann M; Mueller A
    Eur J Endocrinol; 2008 May; 158(5):711-9. PubMed ID: 18426831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome.
    Uslu S; Ozcelik E; Kebapci N; Temel HE; Demirci F; Ergun B; Demirustu C
    Ir J Med Sci; 2016 Feb; 185(1):259-63. PubMed ID: 26232927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new look at the genetic and environmental coherence of metabolic syndrome components.
    Panizzon MS; Hauger RL; Sailors M; Lyons MJ; Jacobson KC; Murray McKenzie R; Rana B; Vasilopoulos T; Vuoksimaa E; Xian H; Kremen WS; Franz CE
    Obesity (Silver Spring); 2015 Dec; 23(12):2499-507. PubMed ID: 26524476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.